Rosalia Caballero

Abstract Pregnancy-associated breast cancer (PABC), diagnosed during or shortly after pregnancy, is a challenging entity with an aggressive biology and poor prognosis. This study analyzed the clinicopathological characteristics and gene expression profile of 33 PABC and 26 non-PABC patients using the nCounter BC360 Panel (NanoString).

The Oncologist 2016;21:150–155; first published on January 19, 2016; http://dx.doi:10.1634/theoncologist.2015-0312 The online version of this article has been amended to correct errors that appear in Table 1 on page 152. A row was added to the “Treatment” section to provide missing MDH treatment data. In the “Histologic grade” section, the percentage noted for “GX” in the “pCR = no” column was incorrect; the correct percentage is 73.3. An errant comma in the “G3” heading was removed.